Perfusion-compatible culture medium for viable pancreatic cancer tissue avatars
A physiologically relevant culture medium designed to maintain the viability, structure, immune composition, and functional characteristics of pancreatic tissue and tumour slices during extended ex vivo culture. Optimised for perfusion systems, it supports patient-derived tumour avatar models used for therapeutic evaluation, biomarker discovery, live tissue imaging, and personalised treatment selection.
Applications: Patient-derived avatars, precision oncology testing, drug response profiling, tumour microenvironment research, spatial transcriptomics studies, immunotherapy evaluation, live tissue imaging
| Features | Benefits |
|---|---|
| Preserves tumour, stromal, and immune microenvironment components during culture | The culture mimics in vivo conditions |
| Compatible with perfusion-based tissue culture systems | Ready for use with automated systems |
| Supports long-term viability of patient-derived pancreatic tumour slices | Allows for therapeutic evaluation, biomarker discovery, live tissue imaging, and personalized treatment selection |
| Low-glucose DMEM formulation designed | Better reflection of physiological conditions |
| Includes soybean trypsin inhibitor | Reduced pancreatic tissue autodigestion |
| Contains broad-spectrum antimicrobial and antifungal protection | Better reflection of physiological conditions |
Patented and Available For
- Co-development
- Consulting
- Licensing